TOC

Article Outline

 

Editorial

1 

State of the Art Review: HLA Matching and Outcome of Unrelated Donor Umbilical Cord Blood Transplants

Naynesh Kamani, Stephen Spellman, Carolyn Katovich Hurley, Juliet N. Barker, Franklin O. Smith, Machteld Oudshoorn, Robert Bray, Anajane Smith, Thomas M. Williams, Brent Logan, Mary Eapen, Claudio Anasetti, Michelle Setterholm, Dennis L. Confer

 

Brief Articles

7 

Alemtuzumab-Induced Resolution of Refractory Cutaneous Chronic Graft-Versus-Host Disease

Guillermo J. Ruiz-Argüelles, Javier Gil-Beristain, Mario Magaña, Guillermo J. Ruiz-Delgado

 

Brief Articles

10 

Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

David Gómez-Almaguer, Guillermo J. Ruiz-Argüelles, Luz del Carmen Tarín-Arzaga, Oscar González-Llano, Homero Gutiérrez-Aguirre, Olga Cantú-Rodríguez, José Jaime-Pérez, Antonio Carrasco-Yalán, Sergio Giralt

 

Biology

16 

Importance of Interleukin-7 in the Development of Experimental Graft-Versus-Host Disease

Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg

 

Clinical Research

28 

A Prognostic Score for Patients with Acute Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Stem Cell Transplantation

Philippe Armand, Haesook T. Kim, Corey S. Cutler, Vincent T. Ho, John Koreth, Jerome Ritz, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer

 

Clinical Research

36 

Long-Term Outcomes of Autologous Stem Cell Transplantation for Follicular Non-Hodgkin Lymphoma: Effect of Histological Grade and Follicular International Prognostic Index

Julie M. Vose, Philip J. Bierman, Fausto R. Loberiza, James C. Lynch, Gregory R. Bociek, Dennis D. Weisenburger, James O. Armitage

 

Clinical Research

43 

Long-Term Outcome after Bone Marrow Transplantation for Aplastic Anemia Using Cyclophosphamide and Total Lymphoid Irradiation as Conditioning Regimen

Yoshihiro Inamoto, Ritsuro Suzuki, Yachiyo Kuwatsuka, Takahiko Yasuda, Taro Takahashi, Akane Tsujimura, Kyoko Sugimoto, Taku Oba, Seitaro Terakura, Yoshiko Atsuta, Makoto Murata, Masafumi Ito, Yoshihisa Kodera, Koichi Miyamura

 

Clinical Research

50 

High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

Adrian J. C. Bloor, Kirsty Thomson, Noha Chowdhry, Stephanie Verfuerth, Stuart J. Ings, Ronjon Chakraverty, David C. Linch, Anthony H. Goldstone, Karl S. Peggs, Stephen Mackinnon

 

Clinical Research

59 

Dose-Reduced Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation for Human Immunodeficiency Virus–Associated Lymphoma: AIDS Malignancy Consortium Study 020

Thomas R. Spitzer, Richard F. Ambinder, Jeannette Y. Lee, Lawrence D. Kaplan, William Wachsman, David J. Straus, David M. Aboulafia, David T. Scadden

 

Clinical Research

67 

Recipient NOD2/CARD15 Variants: A Novel Independent Risk Factor for the Development of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation

Gerhard C. Hildebrandt, Miguell Granell, Alvaro Urbano-Ispizua, Daniel Wolff, Bernd Hertenstein, Hildegard T. Greinix, Julia Brenmoehl, Christian Schulz, Anne M. Dickinson, Joachim Hahn, Gerhard Rogler, Reinhard Andreesen, Ernst Holler

 

Clinical Research

75 

Donor Killer Immunoglobulin-Like Receptor (KIR) Genotype-Patient Cognate KIR Ligand Combination and Antithymocyte Globulin Preadministration Are Critical Factors in Outcome of HLA-C-KIR Ligand-Mismatched T Cell–Replete Unrelated Bone Marrow Transplantation

Toshio Yabe, Keitaro Matsuo, Kouyuki Hirayasu, Koichi Kashiwase, Sumiyo Kawamura-Ishii, Hidenori Tanaka, Atsuko Ogawa, Minoko Takanashi, Masahiro Satake, Kazunori Nakajima, Katsushi Tokunaga, Hidetoshi Inoko, Hiroo Saji, Seishi Ogawa, Takeo Juji, Takehiko Sasazuki, Yoshihisa Kodera, and Yasuo Morishima for the Japan Marrow Donor Program

 

Clinical Research

88 

Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation

Imke H. Bartelink, Robbert G. M. Bredius, Tessa T. Ververs, Martine F. Raphael, Charlotte van Kesteren, Marc Bierings, Carin M. A. Rademaker, J. den Hartigh, Cuno S. P. M. Uiterwaal, Juliette Zwaveling, Jaap J. Boelens

 

Clinical Research

99 

Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell Immunity

Udo F. Hartwig, Marion Nonn, Shamsul Khan, Irina Link, Christoph Huber, Wolfgang Herr

 

Clinical Research

110 

Clinical Evaluation of Oral Chronic Graft-Versus-Host Disease

Nathaniel S. Treister, Earl Francis Cook, Jr., Joseph Antin, Stephanie J. Lee, Robert Soiffer, Sook-Bin Woo

 

Clinical Research

116 

Higher Infused Lymphocyte Dose Predicts Higher Lymphocyte Recovery, Which in Turn, Predicts Superior Overall Survival following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Devendra K. Hiwase, Smita Hiwase, Michael Bailey, Geraldine Bollard, Anthony P. Schwarer

 

Clinical Research

125 

Acute Renal Failure after Nonmyeloablative Stem Cell Transplantation in Adults

Sabina Kersting, Suzanne V. Dorp, Matthias Theobald, Leo F. Verdonck

 

Letter to the Editor

132 

Continuing Erythropoietin During Peripheral Blood Stem Cell Collection in Myeloma: Can It Reduce Toxicity of Autologous Transplants?

Laura Labonté, Tariq Iqbal, Sheryl McDiarmid, Isabelle Bence-Bruckler, Lothar Huebsch, David Allan